1/n 🚨Welcome to #NephMadness tweetorial on Gila Monster 🦎 How can Gila The NephMadness Monster, who lives in the deserts help with the obesity epidemic? According to World Health Organization (WHO), globally 1/8 persons is obese 👇 who.int/news-room/fact…

We are delighted to start a new term with our amazing members of the Social Media Team 🙌 Welcome to our new members Milagros Flores🇲🇽🇭🇳 Srikanth Bathini🇮🇳 and Hamza Rage🇸🇴 Looking forward to working together 🤜🤛

📢 #Tweetorial alert! “No decision about me, without me!” Yes, this is the new mantra for patients with kidney failure before making a valid choice of treatment modality. Let’s talk about Shared Decision Making (SDM) in Dialysis in this #ISNTweetorial 🧵

This tweetorial was developed by ISN Education Social Media Team member Avinash Rao Ullur, MD DrNB FASN AHSCP-CHS, and supported by an unrestricted educational grant from Baxter. #ISNTweetorial

x.com/i/spaces/1owgw… join us 3:30 AM IST 9th May Lots to learn ! Milagros Flores Valerie Luyckx Elliot Koranteng Tannor Avinash Rao Ullur, MD DrNB FASN AHSCP-CHS Jade Teakell MD PhD African Association of Nephrology (AFRAN)

Thanks to Jeff Perl Joanne Bargman Annie-Claire Nadeau-Fredette and Dr. Peter Blake for a wonderful and very informative session at #PDU2024, Montreal.

𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for the next ISN North America and the Caribbean Regional Board-Caribbean College of Family Physicians webinar: "Approach to the Patient with an Elevated Serum Creatinine" 🗣️ Edgar V. Lerma 🇵🇭 🗓️ June 27 🕖 7 pm GMT-5 🔗 Free registration: us02web.zoom.us/meeting/regist…

📍MGRS - evaluation and management by Dr. Nelson Leung ✔️How to detect, the importance of using different techniques, Rx algorithm, post kidney tx MGRS recurrence management #MSKOncoNephCME American Society of Onconephrology

Risk scorings in SMM Memorial Sloan Kettering Nephrology American Society of Onconephrology #MSKOncoNephCME

📍AL amyloidosis - 50-60% renal involvement, Dara based Rx - Kidneys take time to recover. ➡️ Newer immunotherapeutic approaches, bispecific abs, amyloid directed Rx in development. #MSKOncoNephCME American Society of Onconephrology

Data from MSK Note the calculator Memorial Sloan Kettering Nephrology American Society of Onconephrology #MSKOncoNephCME

Amyloidosis: - prognostic factors for renal survival, amyloid renal response criteria based on proteinuria and IMWG renal response criteria based on eGFR criteria. - Notably there are still some lacunae in IMWG criteria which needs a relook. #MSKOncoNephCME American Society of Onconephrology

Mass spectrometry in Onconeph - basics, different analyzers and proteomics. #MSKOncoNephCME American Society of Onconephrology

Pathology - Dr. Samih Nasr: ➡️ Unmasking with paraffin stain is important for ruling out monotypic fibrillary GN, MN and IgAN which are mostly polyclonal ➡️ importance of IgG subtyping in MGRS ➡️ uses of ancillary techniques in Onco-Neph Dx #MSKOncoNephCME American Society of Onconephrology

📍CART cell Rx: 🗝️ Product comparison for indications, CRS rate and median onset of CRS. 🗝️ Management of severe CRS refractory to Tocilizumab + steroids 🗝️ CD 19 CART rx in SOTs 🗝️ Application spectrum of CART rx in SOTRs #MSKOncoNephCME American Society of Onconephrology

BKVNephropathy post kidney Tx - Dr. Ala Abudayyeh - carefully reduce immunosx gauging risks/benefits - Use of CTLs (from the available data) reduces viremia, no improvement in BKVN - not recommended to use fluoroquinolones, leflunomide, cidofovir #MSKOncoNephCME American Society of Onconephrology

VEGFi in Oncology Sandra Herrmann MD, FASN: - time of onset of HTN & proteinuria - Renal adverse events - TMA post intraocular Bevacizumab is a possibility - Monitoring & Rx of HTN (ACEi/ARB) and proteinuria #MSKOncoNephCME American Society of Onconephrology

📍 Should we be satisfied with negative tests for STEC & ADAMTS13 to label as atypical HUS? 📍STEC - doesn't respond to Eculizumab 📍 average recovery ⌛ with Eculizumab: plts 4 days, renal recovery 30 days 📍 not all aHUS respond to Eculizumab #MSKOncoNephCME American Society of Onconephrology

Transplant associated TMA: 📍 3-hit hypothesis in development of TA-TMA 📍New consensus criteria 📍 PK-PD/response based Eculizumab dosing for Rx of TA-TMA 📍Narsoplimab can be tried as a second option - trials on the go American Society of Onconephrology MSK CME

Amazing conference & great get together MSK CME. Thanks to Aisha Shaikh and Sheron Latcha for the great efforts and many congratulations on the success. Some pictures are worth sharing.☺️ Abhijat Kitchlu | Onconephrology Abdullah Jalal Marko Skrtic Swetha Kanduri Chintan Shah American Society of Onconephrology